PepperLedger
COMPOUND LIBRARY·GLUTATHIONE
COMPOUND PROFILE · PEPPERLEDGER

Glutathione (GSH)

Endogenous tripeptide — gamma-L-glutamyl-L-cysteinyl-glycine — produced in every cell
Type
Endogenous tripeptide — the most abundant intracellular antioxidant in the body; declines ~30–40% between ages 20 and 60
Class
Master antioxidant · Phase II detoxification cofactor · Vitamin C and E regenerator · Mitochondrial protectant · Immune modulator · Skin brightening agent
Administration
IV infusion (highest bioavailability — clinic setting) · Oral liposomal (best oral option) · Oral standard (poor bioavailability) · Nebulized (pulmonary) · Subcutaneous injection (emerging)
Half-life
Short in plasma — maintained by continuous intracellular synthesis; IV elevates plasma GSH acutely
Most studied use
Antioxidant support · Liver protection · Skin brightening · Parkinson's neuroprotection · Athletic recovery · IV longevity clinic protocol staple
Regulatory status
Not FDA-approved as a drug · IV glutathione widely administered in wellness and longevity clinics · Oral supplements available without prescription · Inhaled glutathione used off-label for respiratory conditions
Human evidence
Moderate — clinical evidence for Parkinson's (Phase II pilot), liver disease, and skin lightening (RCT). Richie 2015 RCT confirms oral GSH raises blood levels. IV widely used with supporting real-world data.
Preclinical evidence
Extensive — fundamental to all antioxidant and detoxification biology

EDUCATIONAL TOOL — NOT MEDICAL ADVICE

What is glutathione?

Glutathione is the master antioxidant — a title that reflects biochemical reality, not marketing. Every cell in your body produces glutathione from three amino acids (glutamine, cysteine, glycine) and uses it as the primary defense against oxidative damage. Glutathione neutralizes reactive oxygen species directly, regenerates vitamins C and E after they've been oxidized, supports phase II liver detoxification of toxic compounds and drugs, regulates the immune response, and maintains the redox state that keeps cellular proteins in their functional form. Without adequate glutathione, oxidative stress accumulates, detoxification fails, and mitochondrial function declines.

Glutathione levels decline with age — roughly 30–40% between ages 20 and 60 — and drop precipitously under oxidative stress, illness, alcohol, and chronic inflammation. This decline correlates directly with hallmarks of aging: impaired liver function, increased neurodegeneration risk, reduced immune response, and faster cellular aging.

The practical challenge is administration. Oral glutathione is largely broken down in the gut before absorption — the digestive system degrades the tripeptide into its component amino acids rather than absorbing it intact. This is why IV infusion has become the standard clinical delivery method, and why liposomal oral formulations are the preferred oral option. The distinction between standard oral, liposomal oral, and IV glutathione is real and significant — they are not equivalent.

How it works

Direct ROS Neutralization

Glutathione's reduced form (GSH) directly neutralizes reactive oxygen species — hydrogen peroxide, superoxide, hydroxyl radical, and lipid peroxides — by donating electrons. In the process, GSH is oxidized to GSSG (glutathione disulfide). The enzyme glutathione reductase regenerates GSH from GSSG using NADPH. This GSH/GSSG cycle is the primary cellular redox buffer and the reason glutathione is fundamental rather than just another antioxidant.

Vitamin C and E Regeneration

After vitamins C and E neutralize free radicals, they become oxidized and non-functional. Glutathione regenerates both — restoring vitamin C from dehydroascorbic acid and vitamin E from tocopheryl radical. Without adequate glutathione, the antioxidant network fails even if dietary vitamin intake is adequate.

Phase II Liver Detoxification

Glutathione conjugation is the primary phase II liver detoxification reaction — glutathione S-transferases attach GSH to toxic compounds (drugs, environmental chemicals, metabolic byproducts) making them water-soluble for renal excretion. For anyone running multiple compounds, this is the direct mechanism by which the liver processes and eliminates them. Glutathione depletion is the rate-limiting step in hepatic detoxification capacity.

Skin Lightening Mechanism

Glutathione inhibits tyrosinase — the rate-limiting enzyme in melanin synthesis — reducing melanin production in melanocytes. This produces systemic skin brightening and uneven tone correction. The mechanism is well-characterized; the RCT evidence supports the effect. Users who reduce melanin should compensate with SPF, as melanin provides UV protection.

IV vs. liposomal oral vs. standard oral

Route
Bioavailability
Best for
IV infusion
Direct — ~100% systemic
Acute loading, Parkinson's, clinic reset protocol
Liposomal oral
Significantly better than standard
Daily maintenance, skin brightening, liver support
Standard oral capsule
Poor — gut degradation
Budget maintenance with NAC co-supplementation
Subcutaneous injection
High — bypasses gut
Emerging option; less clinical data than IV

What the research shows

STUDYProgress in Neuro-Psychopharmacology and Biological Psychiatry · 1996

Intravenous glutathione in Parkinson's disease — open label pilot

Sechi G et al.

9 Parkinson's patients. IV glutathione 600 mg twice daily for 30 days. Significant improvement in disability rating. The primary human evidence for IV glutathione in neurodegeneration — small study, but 30 years of citation and subsequent real-world clinical use.

View on PubMed →
STUDYEuropean Journal of Nutrition · 2015

Randomized controlled trial of oral glutathione supplementation on body stores of glutathione

Richie JP Jr et al.

54 healthy adults, 6 months, oral glutathione 250–1000 mg/day. Significant increases in blood and lymphocyte glutathione at both doses. Settles the key question — oral glutathione does raise systemic levels over time. But the increase is in blood, not necessarily intracellular and mitochondrial pools.

View on PubMed →
STUDYJournal of Dermatological Treatment · 2012

Glutathione as an oral whitening agent — randomized, double-blind, placebo-controlled study

Arjinpathana N et al.

60 healthy adults, oral glutathione 500 mg/day for 4 weeks vs. placebo. Significant skin lightening effect. Establishes the tyrosinase inhibition mechanism in humans with RCT-level evidence — one of the stronger human trial designs for this application.

View on PubMed →

Community knowledge

Glutathione's community is the broadest of any compound in this library — spanning longevity biohackers, IV wellness clinic users, athletes, people with liver conditions, and people seeking skin brightening. The IV glutathione experience is the most discussed: immediate post-infusion energy and cognitive clarity, skin brightening over weeks, and general wellbeing improvement. The NAD+ + glutathione IV stack is the signature protocol at most longevity clinics — users describe them as synergistic: NAD+ for cellular energy and function, glutathione for oxidative stress clearance and skin. Oral liposomal is strongly preferred over standard capsules; community considers standard oral inadequate for most therapeutic applications.

WHAT THE RESEARCH SHOWS
KNOWN
  • GSH/GSSG cycle is the primary cellular redox buffer — fundamental biochemistry
  • Phase II liver detoxification via glutathione conjugation — well-characterized mechanism
  • Oral glutathione (250–1000 mg/day) raises blood and lymphocyte levels over 6 months (Richie 2015 RCT)
  • Skin lightening via tyrosinase inhibition confirmed in RCT (Arjinpathana 2012)
  • IV glutathione shows functional improvement in Parkinson's patients (Sechi 1996 pilot)
?UNCERTAIN
  • ?Whether oral glutathione adequately replenishes intracellular and mitochondrial GSH pools — vs. IV
  • ?Optimal longevity dosing and frequency for healthy adults
  • ?Whether liposomal absorption advantages translate to meaningfully better clinical outcomes vs. standard oral
  • ?Long-term safety of sustained high-frequency IV infusion
  • ?Whether skin lightening produces meaningful UV protection reduction at typical supplement doses
AI COACH PREVIEW
I want to add IV glutathione to my NAD+ clinic protocol. How often and what dose, and is there a meaningful benefit to doing both together?
The NAD+ + glutathione combination is genuinely synergistic — not just clinic marketing. NAD+ supports sirtuin activity, DNA repair, and mitochondrial function; glutathione addresses the oxidative stress that accumulates in the same cellular processes. They work on complementary pathways and the combination is more than additive anecdotally. Protocol: NAD+ first (500–1000mg over 2–4 hours), then glutathione as a push at the end (600–1200mg over 15–20 minutes). NAD+ first because the slower infusion is more uncomfortable when you're fresh; the glutathione push provides a clean finish. Frequency: quarterly for maintenance, monthly for active longevity protocols. If budget is limiting, prioritize NAD+ for the quarterly resets and add glutathione to every other session rather than every session. Between IV sessions: 500 mg liposomal oral daily maintains baseline — standard capsules are not equivalent. The acute experience difference between IV and liposomal oral is significant; IV produces effects within the infusion that you don't get orally.
CONTINUE IN THE APP

Open PepperLedger to log your glutathione protocol →

Free to join. Log IV sessions, track skin quality over time, and ask the Coach about optimal glutathione dosing for your specific goals.

Free to join · No credit card · 23-day Pro trial included

PepperLedger

Educational tool — not medical advice. PepperLedger is a logging and information tool for adults managing their own protocols. It does not prescribe, diagnose, or treat anything. Always work with a qualified healthcare provider for medical decisions.

IV glutathione requires clinical administration. Oral supplements are available without prescription. This page is educational only. Consult a healthcare provider for IV protocols.

© 2026 Realee AI · PepperLedger